Companies House true 2025-01-01 2025-12-31 false 05662242 uk-bus:Director1 2025-01-01 2025-12-31 05662242 uk-bus:Director2 2025-01-01 2025-12-31 05662242 2025-01-01 2025-12-31 05662242 2025-12-31 05662242 uk-bus:EntityHasNeverTraded 2025-01-01 2025-12-31 05662242 uk-bus:FRS102 2025-01-01 2025-12-31 05662242 uk-bus:FullAccounts 2025-01-01 2025-12-31 05662242 uk-bus:AuditExempt-NoAccountantsReport 2025-01-01 2025-12-31 05662242 2024-12-31 05662242 uk-bus:OrdinaryShareClass1 2025-01-01 2025-12-31 05662242 uk-bus:OrdinaryShareClass2 2025-01-01 2025-12-31 05662242 uk-bus:OrdinaryShareClass3 2025-01-01 2025-12-31 05662242 uk-bus:PreferenceShareClass1 2025-01-01 2025-12-31 05662242 uk-bus:PreferenceShareClass2 2025-01-01 2025-12-31 05662242 uk-bus:PreferenceShareClass3 2025-01-01 2025-12-31 05662242 uk-core:ShareCapitalPreferenceShares 2025-12-31 05662242 uk-core:ShareCapitalPreferenceShares 2024-12-31 iso4217:GBP iso4217:GBP xbrli:shares xbrli:shares

Registered Number 05662242

HIGHPHARM MEDCHEM CO., LTD

Dormant Accounts

31 December 2025

HIGHPHARM MEDCHEM CO., LTD Registered Number 05662242

Balance Sheet as at 31 December 2025

2025 2024
£ £
Called up share capital not paid
10000
10000
Net assets
10000
10000
Issued share capital
10000 Ordinary Shares of £ 1 each 10000 10000
Total Shareholder funds
10000
10000

STATEMENTS

  1. For the year ending 31 December 2025 the company was entitled to exemption under section 480 of the Companies Act 2006 relating to dormant companies.
  2. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
  3. The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
  4. These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

Approved by the Board on 8 January 2026

And signed on their behalf by:
Xiaoming YU, Director